Lupin completes Phase 3 Trials for Lucentis Biosimilar
The study has achieved its primary endpoint of therapeutic equivalence in visual acuity improvement for wet AMD patients,…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
neovascular age-related macular degeneration
Enzene Biosciences launches Ranibizumab to treat neovascular AMD
Ranibizumab biosimilar is the company’s seventh biosimilar